Lucentis Solution For Injection 0.3Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Lucentis: Solution for injection (0.3mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

RANIBIZUMAB (RA ni BIZ oo mab) is an injectable medicine for the eye. It is used to treat wet macular degeneration and macular edema. This medicine helps to slow the disease and may help to maintain vision. It is not a cure.

In-Depth Information

Lucentis 0.3mg/0.05mL Solution for Injection

NDC: 502420082
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Macular Edema Following Retinal Vein Occlusion, Macular Degeneration

Sometimes used for but not FDA approved for the following conditions:
Diabetic Retinopathy, Diabetic Macular Edema

Storage Information
Store in original package until time of use
Refrigerate (between 36 and 46 degrees F)
Protect from light
Do not freeze
Lucentis 0.3mg/0.05mL Solution for Injection

Reported Side Effects for Lucentis 0.3mg/0.05mL Solution for Injection

Fluid Retention Incidence:
<6.0%*
Severity: MODERATE
Onset: DELAYED
Nerve Pain Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Healing Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Injection Site Reaction Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Constipation Incidence:
<8.0%*
Severity: MODERATE
Onset: DELAYED
Red Eyes Incidence:
<7.0%*
Severity: MODERATE
Onset: EARLY
Inflamed Eyes Incidence:
<12.0%*
Severity: MODERATE
Onset: EARLY
Kidney Failure Incidence:
<7.0%*
Severity: SEVERE
Onset: DELAYED
Brain Attack Incidence:
0.2-4.8%*
Severity: SEVERE
Onset: EARLY
Heartburn Incidence:
1.0-6.0%*
Severity: MILD
Onset: DELAYED
Antibody Formation Incidence:
1.0-8.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
1.0-11.0%*
Severity: MODERATE
Onset: DELAYED
Irregular Heart Beat Incidence:
1.0-5.0%*
Severity: SEVERE
Onset: EARLY
Cough Incidence:
1.0-9.0%*
Severity: MILD
Onset: DELAYED
High Cholesterol Incidence:
1.0-7.0%*
Severity: MODERATE
Onset: DELAYED
Eye Inflammation Incidence:
1.0-18.0%*
Severity: MODERATE
Onset: EARLY
Itchy Eyes Incidence:
1.0-12.0%*
Severity: MILD
Onset: RAPID
Secretion Of Tears Incidence:
2.0-14.0%*
Severity: MILD
Onset: EARLY
Cataracts Incidence:
2.0-28.0%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
2.0-11.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
3.0-12.0%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
3.0-8.0%*
Severity: MILD
Onset: DELAYED
Flu Incidence:
3.0-7.0%*
Severity: MILD
Onset: DELAYED
Blurred Vision Incidence:
5.0-18.0%*
Severity: MODERATE
Onset: EARLY
Sore Throat Incidence:
5.0-16.0%*
Severity: MILD
Onset: DELAYED
Engorgement With Blood Incidence:
5.0-11.0%*
Severity: MODERATE
Onset: DELAYED
High Eye Blood Pressure Incidence:
7.0-24.0%*
Severity: SEVERE
Onset: DELAYED
Eye Irritation Incidence:
7.0-15.0%*
Severity: MILD
Onset: RAPID
Eye Pain Incidence:
17.0-35.0%*
Severity: MILD
Onset: EARLY
Bleeding Within The Eye Incidence:
47.0-74.0%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Lucentis

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5